i
Estimated Population-Level Impact of Using a Six-Week Regimen of Daily Rifapentine to Treat Latent Tuberculosis Infection in the United States
-
December 2020
Source: Ann Am Thorac Soc. 17(12):1639-1642 -
Alternative Title:Ann Am Thorac Soc
-
Personal Author:
-
Subjects:
-
Pubmed ID:32916062
-
Pubmed Central ID:PMC7923126
-
Document Type:
-
Funding:
-
Collection(s):
-
Main Document Checksum:
-
File Type:
Details:
Supporting Files
More +